CIPLA LTD FDA Approval ANDA 078030

ANDA 078030

CIPLA LTD

FDA Drug Application

Application #078030

Documents

Letter2009-03-24

Application Sponsors

ANDA 078030CIPLA LTD

Marketing Status

Discontinued001

Application Products

001FOR SOLUTION;ORAL1MG/ML0STAVUDINESTAVUDINE

FDA Submissions

ORIG1AP2009-03-20
LABELING; LabelingSUPPL3AP2011-11-08
LABELING; LabelingSUPPL4AP2016-02-16
LABELING; LabelingSUPPL6AP2020-02-10STANDARD
LABELING; LabelingSUPPL7AP2020-02-10STANDARD

Submissions Property Types

ORIG1Null1
SUPPL3Null8
SUPPL4Null15
SUPPL6Null15
SUPPL7Null15

CDER Filings

CIPLA LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 78030
            [companyName] => CIPLA LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"STAVUDINE","activeIngredients":"STAVUDINE","strength":"1MG\/ML","dosageForm":"FOR SOLUTION;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"STAVUDINE","submission":"STAVUDINE","actionType":"1MG\/ML","submissionClassification":"FOR SOLUTION;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.